Published in
Springer, PharmacoEconomics, 12(39), p. 1429-1442, 2021
DOI: 10.1007/s40273-021-01073-y
Links
Tools
Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer
Journal article published in 2021 by
Martijn J. H. G. Simons 
,
Valesca P. Retèl ,
Bram L. T. Ramaekers ,
Rogier Butter ,
Joanne M. Mankor ,
Marthe S. Paats,
Joachim G. J. V. Aerts ,
Zakile A. Mfumbilwa ,
Paul Roepman ,
Veerle M. H. Coupé ,
Carin A. Uyl-De Groot ,
Wim H. van Harten ,
Manuela A. Joore
,
Valesca P. Retèl ,
Bram L. T. Ramaekers ,
Rogier Butter ,
Joanne M. Mankor ,
Marthe S. Paats,
Joachim G. J. V. Aerts ,
Zakile A. Mfumbilwa ,
Paul Roepman ,
Veerle M. H. Coupé ,
Carin A. Uyl-De Groot ,
Wim H. van Harten ,
Manuela A. Joore
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 